[{"NetIncomeLoss_1_Q1_USD":-56346000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":26243000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":29800000.0,"InterestPaidNet_1_Q1_USD":169000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-118000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":2250000.0,"AssetsCurrent_0_Q1_USD":469996000.0,"LongTermDebt_0_Q1_USD":15300000.0,"LongTermDebtCurrent_0_Q1_USD":3125000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":9743000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-696000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":1320390.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":413000.0,"ResearchAndDevelopmentInProcess_1_Q1_USD":5000000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":2185000.0,"ForeignCurrencyTransactionGainLossRealized_1_Q1_USD":440000.0,"CommonStockSharesIssued_0_Q1_shares":26319000.0,"Assets_0_Q1_USD":481468000.0,"ShareBasedCompensation_1_Q1_USD":6987000.0,"ContractWithCustomerLiability_0_Q1_USD":29249000.0,"DepreciationAndAmortization_1_Q1_USD":307000.0,"OperatingLeaseLiability_0_Q1_USD":7153000.0,"EquityMethodInvestments_0_Q1_USD":1248000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":50050000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":8477000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":7143000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-358000.0,"AccountsReceivableNetCurrent_0_Q1_USD":2007000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"CommonStockValue_0_Q1_USD":26000.0,"ContractWithCustomerAssetNet_0_Q1_USD":2007000.0,"InterestExpenseLongTermDebt_1_Q1_USD":200000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":430000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":47012000.0,"ProceedsFromIssuanceOfDebt_1_Q1_USD":46599000.0,"DeferredRevenueNoncurrent_0_Q1_USD":11313000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-56346000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-5415000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":466839000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":5710000.0,"Liabilities_0_Q1_USD":128861000.0,"Dividends_1_Q1_USD":0.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":6690000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":1534000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q1_USD":7500000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"IncomeLossFromEquityMethodInvestments_1_Q1_USD":1248000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":3370000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q1_USD":1250000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":6987000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-42950000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":1987000.0,"LiabilitiesCurrent_0_Q1_USD":53333000.0,"DeferredRevenueCurrent_0_Q1_USD":17936000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":-2127000.0,"AccountsPayableCurrent_0_Q1_USD":5597000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":413000.0,"LongTermDebtNoncurrent_0_Q1_USD":58147000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.084,"AdditionalPaidInCapital_0_Q1_USD":552743000.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q1_USD":6550000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":238000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":3427000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":466946000.0,"RestrictedCashNoncurrent_0_Q1_USD":107000.0,"CommonStockSharesOutstanding_0_Q1_shares":26319000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-118000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":1324000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-1619000.0,"CommonStockSharesAuthorized_0_Q1_shares":60000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":2127000.0,"OperatingIncomeLoss_1_Q1_USD":-57666000.0,"OperatingLeaseCost_1_Q1_USD":400000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":481468000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":3834000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":6987000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":6797000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1443000.0,"OperatingExpenses_1_Q1_USD":59793000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":1828000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-2.15,"OtherLiabilitiesNoncurrent_0_Q1_USD":358000.0,"StockholdersEquity_0_Q1_USD":352607000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":118000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-200162000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":3944000.0,"StockIssuedDuringPeriodValueAcquisitions_1_Q1_USD":5000000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-1371000.0,"Ticker":"ARCT","CIK":"1768224","name":"ARCTURUS THERAPEUTICS HOLDINGS INC.","OfficialName":"Arcturus Therapeutics Holdings Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"666232551.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210510"}]